** Radiopharm Theranostics RAD.AX leaps as much as 50% to A$0.036; set for biggest ever intraday pct gain
** Biopharma secures private placement agreement with Massachusetts-based Lantheus Holdings LNTH.O to raise $5 mln
** Issue price of A$0.060 represents 150% premium to last close
** Co earlier signed co-development deal with the NASDAQ-listed firm to develop biopharmaceuticals in Australia
** Stock hits its highest level since Dec. 10, 2024
** More than 12.9 mln shares traded, 1.2x the 30-day avg
** RAD fell 67.6% in 2024 - third consecutive bear run since 2022
(Reporting by Kumar Tanishk in Bengaluru)
((Tanishk.Kumar@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。